The stock of Davita Inc (NYSE:DVA) is a huge mover today! About 4.85M shares traded hands or 134.30% up from the average. Davita Inc (NYSE:DVA) has declined 24.14% since March 29, 2016 and is downtrending. It has underperformed by 27.61% the S&P500.
The move comes after 7 months positive chart setup for the $11.96B company. It was reported on Oct, 31 by Barchart.com. We have $86.13 PT which if reached, will make NYSE:DVA worth $5.62 billion more.
Analysts await Davita Inc (NYSE:DVA) to report earnings on November, 1. They expect $0.93 EPS, down 7.00% or $0.07 from last year’s $1 per share. DVA’s profit will be $189.74 million for 15.76 P/E if the $0.93 EPS becomes a reality. After $1.01 actual EPS reported by Davita Inc for the previous quarter, Wall Street now forecasts -7.92% negative EPS growth.
Davita Inc (NYSE:DVA) Ratings Coverage
Out of 6 analysts covering DaVita (NYSE:DVA), 1 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 17% are positive. DaVita has been the topic of 11 analyst reports since August 6, 2015 according to StockzIntelligence Inc. The rating was downgraded by Bank of America to “Neutral” on Tuesday, September 6. As per Thursday, August 6, the company rating was maintained by RBC Capital Markets. The rating was upgraded by Raymond James on Tuesday, September 20 to “Outperform”. The firm earned “Sector Perform” rating on Wednesday, November 4 by RBC Capital Markets. The rating was initiated by Citigroup with “Neutral” on Tuesday, September 6. The firm earned “Market Perform” rating on Wednesday, March 2 by Bernstein. On Tuesday, August 9 the stock rating was maintained by JP Morgan with “Neutral”. RBC Capital Markets maintained the stock with “Sector Perform” rating in Tuesday, February 16 report. JP Morgan initiated the stock with “Neutral” rating in Wednesday, September 16 report.
According to Zacks Investment Research, “DaVita Inc. is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a provider of kidney care, delivering dialysis services for chronic kidney failure and end stage renal disease primarily in the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks primarily in California, Nevada, New Mexico, Florida, Colorado and Washington. DaVita Inc., formerly known as DaVita HealthCare Partners Inc., is headquartered in Denver, Colorado.”
Insitutional Activity: The institutional sentiment increased to 1.04 in Q2 2016. Its up 0.03, from 1.01 in 2016Q1. The ratio is positive, as 34 funds sold all Davita Inc shares owned while 162 reduced positions. 51 funds bought stakes while 153 increased positions. They now own 171.18 million shares or 3.23% less from 176.89 million shares in 2016Q1.
Texas Permanent School Fund owns 52,927 shares or 0.05% of their US portfolio. Allianz Asset Mngmt Ag has invested 0% of its portfolio in Davita Inc (NYSE:DVA). Proshare Advsr Limited Co accumulated 20,007 shares or 0.02% of the stock. Registered Inv Advisor has 7,425 shares for 0.27% of their US portfolio. Sandy Spring Comml Bank has 0.01% invested in the company for 800 shares. Bank Of New York Mellon Corporation owns 1.39M shares or 0.03% of their US portfolio. Financial Engines Advsrs Ltd Llc has 36,142 shares for 2.34% of their US portfolio. Tcw Grp last reported 11,950 shares in the company. Balyasny Asset Mngmt Limited Liability Company has 0.25% invested in the company for 504,619 shares. Locust Wood Capital Advisers Ltd Llc reported 326,098 shares or 2.82% of all its holdings. Cubist Systematic Strategies Limited Liability Com last reported 0.02% of its portfolio in the stock. Parallax Volatility Advisers Limited Partnership has 0% invested in the company for 9,289 shares. Janus Cap Llc has invested 0.07% of its portfolio in Davita Inc (NYSE:DVA). Gru, a New York-based fund reported 84,802 shares. Berkshire Hathaway has invested 2.3% of its portfolio in Davita Inc (NYSE:DVA).
Insider Transactions: Since May 6, 2016, the stock had 0 insider purchases, and 12 selling transactions for $12.53 million net activity. Arway Pamela M also sold $835,216 worth of Davita Inc (NYSE:DVA) on Wednesday, May 25. 20,262 shares were sold by STAFFIERI MICHAEL DAVID, worth $1.48M. Shares for $627,534 were sold by Valine Roger. 1,291 Davita Inc (NYSE:DVA) shares with value of $101,360 were sold by JIGANTI JEANINE MARIE. 538 Davita Inc (NYSE:DVA) shares with value of $41,469 were sold by ZUMWALT LEANNE M. Kogod Dennis had sold 17,700 shares worth $1.37 million on Tuesday, May 17. Rodriguez Javier sold $2.75 million worth of Davita Inc (NYSE:DVA) on Friday, May 13.
More important recent Davita Inc (NYSE:DVA) news were published by: Prnewswire.com which released: “DaVita Named to Dow Jones Sustainability World Index” on October 25, 2016, also Prnewswire.com published article titled: “DaVita is a Clinical Leader in Government Five-Star Rating System”, Prnewswire.com published: “DaVita Inc. Schedules 3rd Quarter 2016 Investor Conference Call” on October 07, 2016. More interesting news about Davita Inc (NYSE:DVA) was released by: Forbes.com and their article: “DaVita Becomes Oversold (DVA)” with publication date: October 24, 2016.
DVA Company Profile
DaVita Inc., formerly DaVita HealthCare Partners Inc., incorporated on April 4, 1994, is a well-known provider of kidney care services. The Firm operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s divisions include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. The Company’s Kidney Care division is a well-known provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD). HCP division is a patient and physician-focused integrated health care delivery and management company.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.